SPVM - ETF AI Analysis
Top Page
Invesco S&P 500 Value with Momentum ETF (SPVM)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the year so far, with recent one- and three-month returns also trending positively.
Top Holdings with Strong Momentum
Several of the largest positions, such as CVS Health, Phillips 66, and Bunge Global, have delivered strong year-to-date performance, helping drive the fund’s results.
Value and Momentum Blend in Financials and Defensive Sectors
The fund combines value and momentum stocks with a large tilt toward financials and meaningful exposure to utilities and consumer defensive names, which can provide a mix of growth potential and some stability.
Negative Factors
High Concentration in Financial Stocks
Over one-third of the portfolio is in financial companies, which increases the fund’s sensitivity to problems in that single sector.
Limited International Diversification
Almost all of the ETF’s holdings are in U.S. companies, so investors get little geographic diversification if the U.S. market struggles.
Moderately High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.
SPVM vs. SPDR S&P 500 ETF (SPY)
AUM139.30M
RegionNorth America
Expense Ratio0.39%
Beta0.67
IssuerInvesco
Inception DateJun 16, 2011
Dividend Yield1.91%
Asset ClassEquity
Index TrackedS&P 500 High Momentum Value Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,044
30 Day Avg. Volume14,602
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
86.59Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering101
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPVM Summary
The Invesco S&P 500 Value with Momentum ETF (SPVM) tracks the S&P 500 High Momentum Value Index, focusing on large U.S. companies that look relatively cheap but whose stock prices have been rising. It holds well-known names like Allstate and CVS Health, and spreads investments across sectors such as financials, utilities, and energy. Someone might invest in this ETF to seek a mix of potential growth and value, while staying diversified within big U.S. companies. A key risk is that these stocks can still be volatile and may go up or down with the overall stock market.
How much will it cost me?The Invesco S&P 500 Value with Momentum ETF (SPVM) has an expense ratio of 0.39%, meaning you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to combine value and momentum strategies, which require more research and adjustments compared to passive funds.
What would affect this ETF?The SPVM ETF, which focuses on U.S. large-cap value stocks with strong momentum, could benefit from a stable economic environment and rising consumer confidence, particularly in sectors like Financials and Consumer Cyclical that make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which could pressure Financials, and regulatory changes or economic slowdowns that impact key industries like Utilities and Health Care. Its reliance on U.S. markets also makes it sensitive to domestic economic conditions.
SPVM Top 10 Holdings
SPVM’s story is all about U.S. value names that still have some wind at their backs, with a big tilt toward financials and energy. Refiners like Marathon Petroleum and Valero Energy are doing the heavy lifting, riding strong momentum and helping power the fund higher, while Phillips 66 adds more fuel to that energy-driven push. On the consumer side, Target has been quietly rising, offering a steadier counterweight. Insurers like Allstate and Travelers are more mixed lately, and United Airlines has been lagging, acting as a bit of a drag on this otherwise momentum-focused value mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Allstate | 1.78% | $2.46M | $65.63B | 28.80% | 74 Outperform | |
| Phillips 66 | 1.77% | $2.45M | $101.79B | 93.91% | 73 Outperform | |
| General Motors | 1.75% | $2.43M | $77.01B | 50.61% | 73 Outperform | |
| Marathon Petroleum | 1.66% | $2.30M | $109.21B | 115.72% | 66 Neutral | |
| Travelers Companies | 1.58% | $2.18M | $77.04B | 34.20% | 78 Outperform | |
| Valero Energy | 1.55% | $2.15M | $106.74B | 136.47% | 69 Neutral | |
| United Airlines Holdings | 1.55% | $2.14M | $36.15B | 4.49% | 74 Outperform | |
| Target | 1.51% | $2.09M | $74.70B | 76.49% | 70 Neutral | |
| Synchrony Financial | 1.47% | $2.03M | $26.00B | 5.70% | 72 Outperform | |
| CVS Health | 1.46% | $2.03M | $123.73B | 31.12% | 64 Neutral |
SPVM Technical Analysis
Positive
―
Price Trends
76.93
Positive
74.34
Positive
71.42
Positive
Market Momentum
0.19
Positive
55.34
Neutral
80.50
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPVM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 77.75, equal to the 50-day MA of 76.93, and equal to the 200-day MA of 71.42, indicating a bullish trend. The MACD of 0.19 indicates Positive momentum. The RSI at 55.34 is Neutral, neither overbought nor oversold. The STOCH value of 80.50 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPVM.
SPVM Peer Comparison
Comparison Results
Performance Comparison
SPVM
Invesco S&P 500 Value with Momentum ETF
77.92
14.94
23.72%
JVAL
JPMorgan U.S. Value Factor ETF
―
―
―
JDVL
John Hancock Disciplined Value Select ETF
―
―
―
BASV
Brown Advisory Sustainable Value ETF
―
―
―
GVUS
Goldman Sachs MarketBeta Russell 1000 Value Equity ETF
―
―
―
FLV
American Century Focused Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents